Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on July 15, 2025
Chronic Pain and Digital Health Drive Pain Management Devices Market, Set for 7.2% CAGR Growth Through 2035
EIN Presswire
·
July 15, 2025
Global health systems shift focus to long-term pain management, placing Pain Management Devices Market at the core of this transition. CA, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Pain management devices market was valued at $7252.8 million in …
World’s Healthcare Leaders to Return to Riyadh for Global Health Exhibition 2025 in October
EIN Presswire
·
July 15, 2025
Doubling in size, Global Health Exhibition is set to host 20 international pavilions – driving further overseas growth for 2025 RIYADH, SAUDI ARABIA, July 15, 2025 /EINPresswire.com/ -- Under the patronage of the Ministry of Health and supported by …
Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th
GlobeNewswire
·
July 15, 2025
Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company …
Hollywood Home Health, Hospice, and Palliative Care to Harness Artificial Intelligence to Enhance Home Health Delivery
EIN Presswire
·
July 15, 2025
Hollywood Home Health, Hospice, and Palliative Care announces strategic investment in artificial intelligence (AI) to enhance operational efficiency. TOLUCA LAKE, CALIFORNIA, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Hollywood Home Health, …
Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML
GlobeNewswire
·
July 15, 2025
SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …
Gain Therapeutics Announces Proposed Public Offering
GlobeNewswire
·
July 15, 2025
BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
ADR Ratio Change
GlobeNewswire
·
July 15, 2025
July 15, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the …
Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue
GlobeNewswire
·
July 15, 2025
AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the …
Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals
GlobeNewswire
·
July 15, 2025
Combined Company to Trade on Nasdaq Under Ticker “IMA” Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) today announced the results of …
Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
GlobeNewswire
·
July 15, 2025
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 15, 2025
LONDON …
Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025
GlobeNewswire
·
July 15, 2025
FORT WORTH, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce …
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025
GlobeNewswire
·
July 15, 2025
CARLSBAD, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended June 30, 2025, before the market opens on Tuesday, July 29, 2025. John …
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results
GlobeNewswire
·
July 15, 2025
KIRKLAND, Wash., July 15, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30, 2025. …
HealthLink Dimensions Sets New Privacy Standard with TRUSTe Certification
EIN Presswire
·
July 15, 2025
Certification affirms HealthLink Dimensions' leadership in operational transparency and responsible data governance for healthcare marketing. ATLANTA, GA, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- HealthLink Dimensions has demonstrated a strong …
Oriflame celebrates 58 Years of empowering entrepreneurs through Social Selling
EIN Presswire
·
July 15, 2025
STOCKHOLM, SWEDEN, July 15, 2025 /EINPresswire.com/ -- Oriflame, a global beauty company with a proud heritage of social selling, is celebrating 58 years of empowering entrepreneurs around the world. Since its foundation in 1967, Oriflame has remained …
Non-Small Cell Lung Cancer Market: Valued at $18.8 Billion in 2024, Expected to Grow at 6.9% CAGR Through 2035
EIN Presswire
·
July 15, 2025
Non-Small Cell Lung Cancer Market grows as immunotherapy approvals by Merck …
Mucopolysaccharidosis Market Epidemiology Report 2025-2035: Pipeline Therapies, Drugs Sales, and Regional Outlook
EIN Presswire
·
July 15, 2025
This report also provides a detailed analysis of the current mucopolysaccharidosis marketed drugs and late-stage pipeline drugs. BROOKLYN, NY, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- The 7 major mucopolysaccharidosis market size reach a value …
Rising UTI Cases in Elderly & Women Drive Market to $11.1B in 2024, with 2.2% CAGR Growth Expected Through 2035
EIN Presswire
·
July 15, 2025
Antibiotic innovation, rising female UTI cases, and diagnostic advances are key drivers shaping the future of the UTI market. CA, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Urinary tract infection market size was valued at $11.1 billion in 2024 …
Minimal Residual Disease Market Epidemiology Report 2025-2035: Pipeline Therapies, Drugs Sales, and Regional Outlook
EIN Presswire
·
July 15, 2025
This report provides a detailed analysis of the current minimal residual disease marketed drugs and late-stage pipeline drugs. BROOKLYN, NY, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- The 7 major minimal residual disease market size reach a …